FDA's NDA And BLA Approvals: Ruby-Fill, Levoleucovorin
Below are FDA's original approvals of NDAs and BLAs issued in the past week. Please see key below chart for a guide to frequently used abbreviations.
You may also be interested in...
Genomic profiling firm Foundation Medicine hires new chief commercial officer; Bardy Diagnostics, developer of cardiac arrhythmia devices, picks a chief operating officer; Lantheus Medical Imaging, producer of diagnostic imaging agents and products; brings aboard a new chief medical officer; and more.